Do They Check for Trichomoniasis During a Pap Smear?

A Pap smear is not designed to detect trichomoniasis and will miss the majority of infections. The Pap test exists to screen for abnormal cervical cells that could indicate cancer or precancerous changes, not to diagnose sexually transmitted infections. That said, a lab technician reading a Pap slide will occasionally spot the pear-shaped Trichomonas vaginalis parasite floating among the cells, and when that happens, the finding usually appears on your results. This incidental detection creates real confusion: many people walk away from a normal Pap result believing they have been screened for STIs when they have not.

What the Pap Smear Actually Looks For

The Pap test collects cells from your cervix so a pathologist can examine them under a microscope for signs of abnormal growth. Its purpose is cervical cancer screening, full stop. When a cytotechnologist reviews the slide, they are looking at cell shape, size, and organization. If they happen to see something unusual along the way, such as a fungal organism that looks like yeast or a parasite that looks like Trichomonas, they can note it on the report. But that is an incidental observation, not the point of the test, and the slide preparation is not optimized for finding parasites.

The distinction matters because the sensitivity of a Pap smear for trichomoniasis is poor. One study comparing diagnostic methods found that the Pap smear picked up only about a third of confirmed trichomoniasis cases, while having very high specificity, meaning if the Pap says it sees Trichomonas, the organism is almost certainly there, but it misses the infection roughly two out of three times.¹ In practical terms, a clean Pap result tells you nothing about whether you have trichomoniasis.

Why So Many People Think a Pap Covers STIs

The belief that a Pap smear screens for sexually transmitted infections is remarkably widespread. One survey found that more than 40% of women believed the Pap test was used to screen for STIs other than HPV, along with ovarian cancer, vaginal cancer, and other conditions it does not actually test for.² A separate study of younger women found that roughly 43% thought a Pap smear was the same thing as an STD test.³ Another study documented that about a quarter of participants believed their Pap screened for gonorrhea and chlamydia specifically.⁴

These misconceptions are dangerous for a simple reason: if you believe a Pap smear has already tested you for trichomoniasis (or chlamydia, or gonorrhea), you will not ask for separate STI testing. You may also tell a new partner you have been “tested for everything” when in fact you have not been tested for most STIs at all. The Pap test and STI screening sometimes happen during the same clinic visit, which adds to the confusion, but they are separate tests that your provider must order individually.

What Happens If Trichomonas Shows Up on Your Pap

When a Pap report mentions Trichomonas vaginalis as an incidental finding, the standard recommendation is to treat the infection. Clinical guidance supports prescribing treatment based on this finding alone.⁵ However, because the Pap is not a validated screening tool for this parasite, many clinicians will order a confirmatory test before or alongside treatment. A cervical smear cannot serve as a screening test for trichomoniasis, and when the parasite is noted on a result, a confirmatory culture or nucleic acid amplification test (NAAT) is recommended.⁶

So if your Pap report says Trichomonas was seen, take it seriously. The specificity of the finding is very high, so a positive result is almost always a real infection. But the reverse is not true: a Pap that does not mention Trichomonas provides no reassurance that you are infection-free.

Tests That Actually Diagnose Trichomoniasis

If you want to know whether you have trichomoniasis, you need a test designed for that purpose. The options vary widely in accuracy and availability.

The oldest and cheapest method is a wet mount, where a clinician places a swab of vaginal fluid on a slide with a drop of saline and looks for the parasite’s characteristic twitching movement under a microscope. Wet mounts are fast and can be done in the office, but their sensitivity is limited. Different studies place wet-mount sensitivity somewhere between 40% and 60% compared to more advanced methods.⁷⁸ The parasite has to be alive and moving when the slide is examined, so delays between sample collection and reading further reduce accuracy.

Culture testing grows the organism in a nutrient broth and has historically been considered the reference standard, with sensitivity around 70–75%.⁷ Culture takes several days for results, which is a drawback in clinical settings where same-day answers matter.

Nucleic acid amplification tests, often called NAATs or PCR tests, are the most accurate option available. A systematic review and meta-analysis found that real-time PCR achieved a sensitivity of about 99% and specificity of 100% for detecting the parasite.⁹ These tests detect the parasite’s genetic material, so the organism does not need to be alive at the time of testing. Cost and lab availability have historically limited their use, but they are becoming more accessible and are now considered the best option for detection.¹⁰

Interestingly, one study found that combining a wet mount with a Pap smear raised sensitivity to over 90%, significantly higher than either test alone.¹¹ That combination is still far from ideal compared to molecular testing, but it highlights that the Pap’s low sensitivity is partly a problem of relying on it alone.

Who Gets Screened and Who Does Not

Here is something that surprises many people: there is no routine screening recommendation for trichomoniasis in the general population. The only group for whom routine screening is currently recommended is women living with HIV.¹² For everyone else, testing is typically done only when symptoms are present or when a patient specifically requests it.

This lack of routine screening is a problem because trichomoniasis is extremely common and often completely silent. Globally, an estimated 156 million new cases occurred in a single year among adults aged 15–49.¹⁰ A systematic review looking at women in low- and middle-income countries found that roughly 57% of trichomoniasis infections produced no symptoms at all.¹³ In the United States, the infection rate among women was estimated at about 1.8% in a national survey, though researchers noted this was likely an undercount.¹⁴

The combination of high prevalence, frequent asymptomatic carriage, and symptom-driven testing means many infections go undetected and untreated for months or years. If you are sexually active and have never specifically asked for a trichomoniasis test, you have almost certainly never been tested for it.

Symptoms When They Do Appear

When trichomoniasis causes symptoms in women, the classic presentation includes a yellow or greenish vaginal discharge, an abnormal vaginal odor, and vulvar itching. A study analyzing clinical signs found strong associations between trichomoniasis and yellow discharge, vulvar itching, purulent discharge, and redness of the vagina and vulva.¹⁵ One particularly distinctive finding is colpitis macularis, sometimes called “strawberry cervix,” a pattern of tiny red spots on the cervix visible during a pelvic exam. That same study found a very strong association between trichomoniasis and strawberry cervix, but the sign is only visible in a minority of cases.

In men, trichomoniasis is usually asymptomatic but can occasionally cause urethral irritation or a thin discharge. Men clear infections more quickly than women, but while infected they act as a reservoir, passing the parasite back and forth with partners. One study testing male sexual partners of women with confirmed trichomoniasis found that about 73% of those men were also infected.¹⁶ This finding underscores why treating both partners simultaneously matters for preventing reinfection.

Why Trichomoniasis Is Not Just a Nuisance

Trichomoniasis is often treated as a minor annoyance, but the research tells a more serious story, especially for pregnant women and people at risk for HIV.

Multiple systematic reviews have linked trichomoniasis during pregnancy to preterm delivery, premature rupture of membranes, and low birth weight. One meta-analysis found roughly a 40% increase in the risk of preterm birth and a similar increase in the risk of premature membrane rupture among infected pregnant women.¹⁷ A separate meta-analysis found comparable risk increases and also identified an association with infants born small for gestational age.¹⁸ Given the high rate of asymptomatic infection, many pregnant women who carry the parasite will never know unless they are specifically tested.

The link between trichomoniasis and HIV acquisition is also well established. The parasite damages the vaginal and cervical lining, triggers an inflammatory immune response that actually brings more HIV-susceptible immune cells to the area, and is associated with bacterial vaginosis, itself a risk factor for HIV.¹⁹ This is the reason routine screening is recommended for women living with HIV: the two infections feed off each other.

The Bacterial Vaginosis Connection

Trichomoniasis and bacterial vaginosis (BV) frequently occur together, and this overlap complicates diagnosis and treatment. Among HIV-positive women with trichomoniasis, the rate of concurrent BV was about 61% in one study.²⁰ A systematic review and meta-analysis found that women with BV had roughly double the odds of acquiring trichomoniasis compared to women without BV.²¹

The practical takeaway is that if you are being treated for recurrent BV, it is worth asking your provider to test for trichomoniasis as well. BV and trichomoniasis share symptoms like abnormal discharge and odor, and treating one without addressing the other can leave you in a frustrating cycle of recurring problems. A study of pregnant women in Nigeria documented that about 15% of those with vaginal infections had both BV and trichomoniasis simultaneously.²²

Treatment and the Problem of Resistance

Trichomoniasis is treated with nitroimidazole drugs, most commonly metronidazole or tinidazole. These medications are effective at clearing the infection in the vast majority of cases, and treating sexual partners at the same time reduces reinfection rates.²³ Treatment is straightforward for most people: a short course of oral medication.

The challenge arises in cases of drug resistance. Because there are no approved alternative drug classes for trichomoniasis, patients with resistant infections face a difficult situation. The only option is higher and sometimes toxic doses of metronidazole, which can cause unpleasant side effects including nausea, metallic taste, and in severe cases, nerve damage.²⁴ Resistant cases are uncommon, but they highlight how limited the treatment toolkit remains for this particular parasite compared to, say, bacterial STIs that can be treated with multiple antibiotic classes.

How to Actually Get Tested

If you want to be tested for trichomoniasis, you need to ask for it explicitly. Even at a clinic visit that includes a Pap smear and a pelvic exam, trichomoniasis testing is typically not part of the standard panel unless you are in a high-risk group or you report symptoms. Many STI panels test for chlamydia and gonorrhea by default but leave trichomoniasis off the list entirely.

When you request testing, ask specifically for a NAAT or PCR test if available. These tests can often be run on the same vaginal swab used for chlamydia and gonorrhea testing, so in many cases no additional sample collection is needed. If molecular testing is not available at your clinic, a wet mount performed immediately (while the sample is still fresh) is a reasonable alternative, though you should understand its limitations. A negative wet mount does not rule out infection.

Self-collected vaginal swabs work well for NAAT-based trichomoniasis testing, which means you may not even need a pelvic exam to get tested. Some clinics and mail-order testing services allow you to collect your own sample. For men, a urine sample can be tested by NAAT, though testing men for trichomoniasis is even less routine than testing women, despite the high transmission rates between partners.

Partner Treatment and the Reinfection Cycle

One of the most frustrating aspects of trichomoniasis is the reinfection cycle. Because male partners are frequently infected but almost never symptomatic, treating only the woman who tested positive leaves the couple at high risk of reinfection as soon as they resume sexual contact. The finding that nearly three-quarters of male partners of infected women also carry the parasite makes this point clearly.¹⁶

Expedited partner therapy, where a clinician prescribes medication for the patient’s partner without requiring the partner to come in for a visit, is one approach that has gained traction. Both partners should avoid sexual contact until treatment is complete and symptoms have resolved. Without simultaneous partner treatment, reinfection rates climb, and the cycle continues. If you have been diagnosed with trichomoniasis and your provider does not mention partner treatment, bring it up yourself. It is one of the most practical steps you can take to avoid a repeat infection.